Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Stanley FrankelDirector | Precision BiosciencesDTIL | Open-market buy | 09/28 | 09/30 | 1,000 sh | $6.00 | $6,000 | +2.5% |
Geno J. GermanoDirector | Precision BiosciencesDTIL | Open-market buy | 09/25 | 09/29 | 2,609 sh | $6.28 | $16,384.52 | +5.8% |
Melinda BrownDirector | Precision BiosciencesDTIL | Open-market buy | 09/25 | 09/29 | 1,135 sh | $6.27 | $7,116.45 | +2.6% |
Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 02/18 | 02/19 | 8,149 sh | $3.84 | $31,292.16 | −6.1% | |
Smith J. JeffersonChief Research Officer | Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 02/18 | 02/19 | 4,925 sh | $3.84 | $18,912 | −3.9% |
Scimeca DarioGeneral Counsel and Secretary | Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 02/18 | 02/19 | 4,925 sh | $3.84 | $18,912 | −8.0% |
Amoroso MichaelPresident and CEO | Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 02/18 | 02/19 | 20,559 sh | $3.84 | $78,946.56 | −7.8% |
Amoroso MichaelPresident and CEO | Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 01/22 | 01/22 | 34,799 sh | $4.17 | $145,111.83 | −15.1% |
Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 01/21 | 01/22 | 15,213 sh | $4.03 | $61,308.39 | −12.5% | |
Smith J. JeffersonChief Research Officer | Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 01/21 | 01/22 | 10,200 sh | $4.03 | $41,106 | −8.5% |
Scimeca DarioGeneral Counsel and Secretary | Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 01/21 | 01/22 | 8,854 sh | $4.03 | $35,681.62 | −16.5% |
Geno J. GermanoDirector | Precision BiosciencesDTIL | Open-market buy | 25/12/16 | 25/12/17 | 3,000 sh | $4.72 | $14,160 | +14.4% |
Stanley FrankelDirector | Precision BiosciencesDTIL | Open-market buy | 25/12/16 | 25/12/17 | 2,700 sh | $4.70 | $12,690 | +16.1% |
Melinda BrownDirector | Precision BiosciencesDTIL | Open-market buy | 25/12/15 | 25/12/17 | 1,381 sh | $4.97 | $6,863.57 | +6.3% |
Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 25/11/03 | 25/11/04 | 1,303 sh | $6.49 | $8,456.47 | −1.7% | |
Scimeca DarioGeneral Counsel and Secretary | Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 25/11/03 | 25/11/04 | 665 sh | $6.49 | $4,315.85 | −2.3% |
Amoroso MichaelPresident and CEO | Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 25/11/03 | 25/11/04 | 3,409 sh | $6.49 | $22,124.41 | −2.9% |
Stanley FrankelDirector | Precision BiosciencesDTIL | Open-market buy | 25/09/26 | 25/09/30 | 2,700 sh | $4.97 | $13,419 | +19.2% |
Melinda BrownDirector | Precision BiosciencesDTIL | Open-market buy | 25/09/22 | 25/09/24 | 1,400 sh | $4.89 | $6,846 | +6.8% |
Precision BiosciencesDTIL | Open-market sale10b5-1 plan | 25/07/03 | 25/07/08 | 14,827 sh | $4.26 | $63,163.02 | −16.8% |
